Infinity Pharmaceuticals Inc (OTCPK:INFIQ)
$ 0.000001 0 (0%) Market Cap: - Enterprise Value: -17.12 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Q1 2022 Infinity Pharmaceuticals Inc Earnings Call Transcript

May 03, 2022 / 08:30PM GMT
Release Date Price: $0.84 (+6.99%)
Operator

Ladies and gentlemen, thank you for standing by. Welcome to the Infinity Pharmaceuticals conference call to discuss the company's operations and First Quarter 2022 Financial Results. My name is Sarah, and I'll be your operator for today's call. (Operator Instructions)

Now I would like to introduce your host for today's call, Jayne Kauffman. Please go ahead.

Jayne Kauffman
Infinity Pharmaceuticals, Inc. - Senior Executive Coordinator

Thank you, Sarah, and good afternoon, everyone. Welcome to today's call to discuss our recent business progress and review of our first quarter 2022 financial results and company highlights. On the call with me today are Adelene Perkins, Chief Executive Officer and Chair; Larry Bloch, President; and Robert Ilaria, Jr., Chief Medical Officer. We'll open up the call for Q&A following our remarks. The press release issued today details our results and is available on our website at infi.com.

Please note that during this call, we may make forward-looking statements about our future expectations and plans,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot